PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Pacl...

por Bertucci, Alexandre, Bertucci, François, Zemmour, Christophe, Lerebours, Florence, Pierga, Jean-Yves, Levy, Christelle, Dalenc, Florence, Grenier, Julien, Petit, Thierry, Berline, Marguerite, Gonçalves, Anthony
Publicado en Front Oncol (2020)